Facebook Linkedin Twitter
Home Topics Translational Research Page 242

Translational Research

Drug demonstrates significant activity in patients with platinum-refractory urothelial cancer. [National Cancer Institute]
News & Features

Urothelial Cancer Gets Aid from Precision Medicine

0
Researchers have successfully characterized the mutational landscapes of glycosylation-associated genes in colon cancer
News & Features

Protein Glycosylation Enzymes Contribute to Colon Cancer Progression

0
Source: DepositPhotos
News & Features

Snapshot: The Brain-to-Brain Loop in Molecular Oncology Laboratory Testing

George D. Lundberg and Clifford Baron, M.D., Ph.D.
0
A new assembly of the gorilla genome offers important biological insights into their evolution and how these primates differ from humans. [Alice C. Gray]
Molecular Dx

New Technology Aids in Completion of Gorilla Genome Sequence

0
One of the major scientific crusades in oncology has been to identify and validate biomarkers associated with recurrent breast cancer. [iStock / royaltystockphoto]
Molecular Dx

Case Study: Breast Cancer YAPI (Yet Another Prognostic Indicator) Revisited: ASCO Recommendations

Stephen C. Peiper, M.D. and Zi-Xuan Wang, Ph.D.
0
An increasing number of clinicians are adding the cancer transcriptome to their precision medicine program. They have found that the transcriptome is important in identifying clinically impactful results. [iStock / DeoSum]
Molecular Dx

Deciphering the Cancer Transcriptome

Richard A. Stein, M.D., Ph.D.
0
Bringing molecular diagnostics to market is an arduous process dotted with regulatory issues and decisions affecting the long term future of the product. Yet it is a critical part of fostering the possibilities within precision medicine. [iStock / KEXINO]
Molecular Dx

The Potential of Precision Medicine Rests in Bringing Molecular Diagnostics to Market

Jeffrey S. Buguliskis, Ph.D.
0
Some researchers believe that while tumor genome profiling identifies driver mutations in breast tumors
Molecular Dx

Finer Cancer Screens Catch More Cancer Clues

Patricia Fitzpatrick Dimond, Ph.D.
0
A new study found a single variant that may underlie the genetic basis for some disparities in cancer incidence and outcomes in African-descent populations. [NCI]
News & Features

Tumor Suppressor Variant May Be Cause of Increased Cancer Risk in African Americans

0
Whole exome sequencing is becoming more available to patients and will help them distill the sequencing data to candidate genes and link them with therapies. [NCI]
Molecular Dx

Mining Whole Exome Sequencing Data for Better Cancer Therapies

0
1...241242243...263Page 242 of 263

Related Content

Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.
Inside Precision Medicine